Can I use a vendor agent and still keep my data private?

Sometimes — check the BAA, data-retention terms, and explicitly whether your data is used to train the vendor's models. If any of those are unacceptable for your PHI, that pushes you toward building inside your own boundary.

What's the fastest way to decide?

Ask three questions: Does this agent differentiate us? Does it need deep access to our PHI/workflows? Do we need to own the compliance boundary? Mostly "yes" → build. Mostly "no" → buy a proven point solution.

Which foundation model should power a healthcare AI agent?

It matters less than teams expect — the leading models (Claude, GPT, Gemini) are all capable enough that the model isn't your moat. What matters more is choosing a provider that will sign a BAA for PHI, then investing in retrieval over your own data, workflow integration, and evaluation. Keep the model swappable so you can move as capability and pricing shift.

How do I stop a healthcare AI agent from hallucinating?

You contain it rather than eliminate it entirely: ground answers in your own data with retrieval (RAG), constrain the agent with tools and guardrails, keep a human in the loop wherever the output is clinical, and run a real evaluation harness against known cases before and after every change. That discipline — not the model choice — is what makes an agent safe enough for healthcare.

Do healthcare AI agents need a BAA?

If the agent processes PHI, yes — you need a signed BAA with any model provider or vendor in the data path, and you should confirm your data isn't used to train their models. If a provider won't sign one, or the terms don't fit your PHI, that's a strong push toward running inference inside your own compliance boundary.

Build vs Buy

Build vs Buy: AI Agents in Healthcare

Buy a vendor AI agent for a well-defined, commodity task — ambient scribing, eligibility checks, appointment voice bots — where a proven point solution beats reinventing it. Build custom when the agent touches your differentiated workflows, needs deep access to your clinical data, or must run inside a compliance and data-governance boundary you control. The deciding questions are differentiation, PHI control, and integration depth — not model quality, since everyone uses similar foundation models.

15-Minute Scoping Call All Comparisons

Quick answer

Commodity task, proven vendor → buy. Differentiated workflow, PHI control, deep integration → build. Model choice isn't the differentiator; data and workflow are.

Decision table at a glance

Criterion	Build	Buy
Time to value	Longer (build + eval)	Fast (configure)
Differentiation	High — it's yours	Low — same product others buy
PHI / data control	Full, in your boundary	Shared with vendor
Integration depth	As deep as you build	Vendor's connectors
Compliance ownership	You own it	Vendor BAA + your oversight
Cost model	Build + infra + model tokens	Per-seat / per-call fees
Maintenance	On you (prompts, evals, drift)	On the vendor

What they are

What is Build

Building means composing your own agents on foundation models (Claude, GPT, Gemini) plus orchestration, retrieval over your clinical data, tools/integrations, and guardrails — inside your own compliance boundary. You own the prompts, the data flows, the evaluation harness, and the ability to tune behavior to your workflows.

What is Buy

Buying means licensing a purpose-built healthcare AI product — an ambient scribe, a prior-auth automation, a patient-communication bot — that's already trained, integrated with common EHRs, and shipped with its own compliance posture (BAA, certifications). You get speed and a maintained product; you accept its boundaries.

Key differences

The model isn't the moat

Everyone builds on the same foundation models, so "we use a better LLM" isn't a durable advantage. The differentiation lives in your data, your workflow integration, and your evaluation/guardrail discipline. If those are what set the agent apart, build. If the task is generic, a vendor already commoditized it — buy.

PHI, compliance, and the trust boundary

Healthcare agents touch PHI, so where inference runs and how data flows matters enormously. Building lets you keep everything inside your BAA-covered, audited boundary with data-residency control. Buying means trusting a vendor's compliance posture — acceptable for many tasks, but verify the BAA, retention, and whether your data trains their models.

Total cost and scale dynamics

Vendor per-seat or per-call pricing is cheap to start and scales with usage; custom carries build cost plus infra and model-token spend that you can optimize. As volume grows, custom economics can win — but only if you have the team to run evals, manage prompt/behavior drift, and keep the system safe.

Orchestration vs single function

Buying works best for a single, bounded function. If your ambition is a multi-agent system — several agents coordinating across intake, documentation, coding, and follow-up with shared context and tools — that orchestration is inherently custom, even if individual capabilities lean on vendor components.

When to use each

When to use Build (Custom Agents)

The agent automates a workflow that differentiates you, not a commodity task.
It needs deep, governed access to your PHI, EHR, and proprietary data (RAG on clinical records).
You require full control of the compliance boundary, audit trail, and data residency.
You want to avoid per-seat/per-call vendor fees compounding at scale.
You're orchestrating multiple agents and tools into a system, not buying one function.

When to use Buy (Vendor Point Solution)

The task is well-defined and commoditized (scribing, eligibility, scheduling voice AI).
A mature vendor already solves it well with EHR integrations you need.
You want a signed BAA and the vendor's compliance/security work done for you.
You lack ML/LLM engineering capacity and speed matters more than customization.
You're validating whether AI moves the metric before investing in custom.

AI Agents for Healthcare Multi-Agent Systems for Healthcare Generative AI for Healthcare Healthcare RAG / Chat-with-Records

Frequently Asked Questions

Risk comes from weak evaluation and guardrails, not from building per se. A custom agent with a rigorous eval harness, human-in-the-loop where clinically appropriate, and a controlled PHI boundary can be safer than a black-box vendor tool. The discipline matters more than the buy/build choice.

Not sure which fits your build?

Tell us about your product, integration targets, and timeline. We'll map the trade-offs to your context and recommend the path that gets you to a compliant launch fastest.

15-Minute Scoping Call Explore Solutions